Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Takeo Yasu"'
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4871-4879 (2023)
Cabozantinib, which is used to treat renal cell and hepatocellular carcinomas, is often associated with dose-dependent adverse events. Monitoring the levels of cabozantinib in the blood may maximize the therapeutic effect and prevent serious adverse
Externí odkaz:
https://doaj.org/article/0327723aaf41435f97c5eed0094c0a1b
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9826-9832 (2022)
Management of tumor lysis syndrome (TLS) associated with cancer chemotherapy for malignant tumors is important because of its potentially fatal course. The use of rasburicase, a recombinant urate oxidase, is recommended for TLS; however, because rasb
Externí odkaz:
https://doaj.org/article/e1805caff25f48b5a0235a591d0ae0b5
Publikováno v:
Current Oncology, Vol 29, Iss 5, Pp 3242-3251 (2022)
Invasive fungal disease (IFD) is an important cause of morbidity and mortality in patients with hematological malignancies. As chronic lymphocytic leukemia (CLL) is a rare hematological malignancy in Japan, IFD incidence in Japanese patients with CLL
Externí odkaz:
https://doaj.org/article/7f961038371e4c389899aa1568a0cfde
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 2 (2023)
Introduction Hypoglycemia is listed as an adverse effect in the package inserts of not only hypoglycemic agents but also many other drugs. We aimed to clarify real-world factors related to an increased risk of hypoglycemia-related hospitalization (HR
Externí odkaz:
https://doaj.org/article/a7f2816bb77f4467ae20bfe552f4fc8f
Autor:
Yasuhiro Araki, Kenji Momo, Takeo Yasu, Kohtaro Ono, Takeshi Uchikura, Masayoshi Koinuma, Tadanori Sasaki
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Antimicrobial resistance is a major health concern. A primary cause is the inappropriate use of antimicrobials, particularly by patients with upper respiratory tract infection. However, baseline information for antibiotic use for common cold
Externí odkaz:
https://doaj.org/article/6a45e4f7af704b248c570ab1871c3017
Autor:
Shunsuke Kobayashi, Takeo Yasu, Seiji Tagawa, Takashi Ogura, Akira Kitaoka, Masaaki Matsubara
Publikováno v:
Acta Ortopédica Brasileira, Vol 30, Iss spe2 (2022)
ABSTRACT Objective Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI proph
Externí odkaz:
https://doaj.org/article/fcff7e743125485a963d7700d9fb073e
Autor:
Megumi Takano, Motoki Inoue, Yuko Ikeda, Hidenori Kage, Tohru Inokawa, Kazuhiko Nakadate, Takeo Yasu, Yasumasa Tsuda, Kazumi Goto
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5729 (2023)
Blinatumomab (Blincyto® injection solution) is classified as a bispecific T-cell engaging (BiTE) antibody and is intended for the treatment of relapsed/refractory acute lymphoblastic leukemia. It requires continuous infusion to maintain therapeutic
Externí odkaz:
https://doaj.org/article/8db6e099d4b541a0a8a13f6ca464980c
Autor:
Takeo Yasu, Yuka Nomura, Yoshito Gando, Yasuhiko Matsumoto, Takashi Sugita, Nobuharu Kosugi, Masayuki Kobayashi
Publikováno v:
Journal of Fungi, Vol 8, Iss 10, p 1035 (2022)
Voriconazole is an antifungal drug used to treat invasive aspergillosis. Voriconazole exhibits nonlinear behavior and considerable individual variability in its pharmacokinetic profile. Invasive aspergillosis has a poor prognosis, and failure of trea
Externí odkaz:
https://doaj.org/article/58c4bcc806f643779f2fd687eed57c6a
Autor:
Kenji Momo, Haruna Kobayashi, Yuuka Sugiura, Takeo Yasu, Masayoshi Koinuma, Sei-Ichiro Kuroda
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0225297 (2019)
This study aimed to compare and determine the prevalence of drug-drug interaction (DDI) and bleeding rate in atrial fibrillation (AF) patients receiving anticoagulants in a clinical setting. We used large claims data of AF patients obtained from the
Externí odkaz:
https://doaj.org/article/df5991c1892b4bcca8ab949f233392fc
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223431 (2019)
BackgroundThe extent of medication adherence in patients with type 2 diabetes mellitus (T2DM) several years after starting treatment with hypoglycemic agents remains unknown. Most previous work on medication adherence targeting this group of patients
Externí odkaz:
https://doaj.org/article/b8a4564ee0714c4486462b113ff29a54